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Abstract
The heparan sulfate (HS) chains of proteoglycans are a key regulatory component of the extracellular matrices of animal
cells, including the pericellular matrix around the plasma membrane. In these matrices they regulate transport, gradient
formation, and effector functions of over 400 proteins central to cell communication. HS from different matrices differs in its
selectivity for its protein partners. However, there has been no direct test of how HS in the matrix regulates the transport of
its partner proteins. We address this issue by single molecule imaging and tracking in fibroblast pericellular matrix of
fibroblast growth factor 2 (FGF2), stoichiometrically labelled with small gold nanoparticles. Transmission electron
microscopy and photothermal heterodyne imaging (PHI) show that the spatial distribution of the HS-binding sites for FGF2
in the pericellular matrix is heterogeneous over length scales ranging from 22 nm to several mm. Tracking of individual FGF2
by PHI in the pericellular matrix of living cells demonstrates that they undergo five distinct types of motion. They spend
much of their time in confined motion (,110 nm diameter), but they are not trapped and can escape by simple diffusion,
which may be slow, fast, or directed. These substantial translocations (mm) cover distances far greater than the length of a
single HS chain. Similar molecular motion persists in fixed cells, where the movement of membrane PGs is impeded. We
conclude that FGF2 moves within the pericellular matrix by translocating from one HS-binding site to another. The binding
sites on HS chains form non-random, heterogeneous networks. These promote FGF2 confinement or substantial
translocation depending on their spatial organisation. We propose that this spatial organisation, coupled to the relative
selectivity and the availability of HS-binding sites, determines the transport of FGF2 in matrices. Similar mechanisms are
likely to underpin the movement of many other HS-binding effectors.
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Introduction
The notion of gradients of morphogens and of epithelial-
mesenchymal signal relays is common currency in developmental
biology [1–4]. Moreover, organism homeostasis often depends on
similar transport of effector proteins, such as growth factors,
cytokines, and chemokines from source to target cell, for example,
in wound repair and in the regulation of immune responses [5].
Such transport occurs in the extracellular matrix that lies between
cells, including the pericellular matrix adjacent to the plasma
membrane, where the heparan sulfate (HS) chains of proteogly-
cans (PGs) are the dominant molecular species [6]. This
dominance is due to their size (,40 nm to 160 nm long), amount,
and unlike the other extracellular glycans, their large array of
protein partners (over 400), which they bind with varying degrees
of selectivity [7,8]. These protein partners include most protein
effectors that mediate cell communication (e.g., morphogens,
chemokines, cytokines, growth factors, matrix proteins, and their
cognate cellular receptors).
HSPG possess a core protein (transmembrane, glycopho-
sphatidyl inositol anchored or soluble), to which one or more
HS chains are attached. A particular feature is the long,
unbranched glycosaminoglycan chain, in which tracts of variably
sulfated saccharides, responsible for the interaction with proteins,
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alternate with non-sulfated sequences of sugars [9]. A single chain
of HS contains multiple, even overlapping, protein binding sites
[10]. In addition, one particular sequence of sulfated sugars in a
chain can bind different ligands with different affinities (e.g., [11]),
and vice versa, a single ligand can bind to several sequences of
sugars. The binding of ligands to HS chains is governed by relative
selectivity rather than absolute specificity and there is substantial
overlap at the level of the sugar sequences recognised by different
proteins [12]. This conclusion is reinforced by the demonstration
that some unrelated sulfated plant polysaccharides possess
structures that allow effective interaction with HS-binding proteins
[13].
Impairing the interaction of HS with its protein partners has
been shown to alter gradient formation, as well as short- to long-
range signalling for many morphogens and regulatory proteins
[e.g., hedgehog, wingless (WNT), decapentaplegic (DPP, ortholog
of vertebrate bone morphogenic protein), and fibroblast growth
factors (FGF)] [1–3,14–19]. The many experiments of this type
demonstrate the crucial role of HS in the regulation of the
transport of effectors. Despite the considerable overlap in the
structures of the binding sites in HS recognised by its many protein
partners, it is well established that HS can also be selective for
these partners, which has been evidenced in matrices from
different tissues (e.g., [20–23]). In addition, matrices are dynamic,
so the selectivity of their HS for protein partners changes over
time, which is particularly evident in development [24]. Thus, the
expression of sequences of sulfated sugars can be spatially and
temporally regulated in tissues, which tunes the interaction of
protein partners with HS and regulates their effector and transport
functions. However, how HSPG regulate the transport of its
protein partners in matrices remains debated, because this has not
been measured directly (reviewed in [19]).
To address this issue, we have used a new generation of gold
nanoparticle probes (10 nm diameter) [25] to stoichiometrically
label FGF2 morphogen, the archetypal HS-binding growth factor,
and examine its distribution and dynamic fluctuations in the
pericellular matrix of Rama 27 fibroblasts. To identify FGF2
associated with FGF receptor (FGFR), a heparin-derived dodeca-
saccharide, degree of polymerisation (DP) 12, was used to prevent
interaction with endogenous HS. Ternary complexes of FGF2-
NP:DP12:FGFR were found to be less mobile than FGF2
associated with HS. In the absence of exogenous DP12, we show
that virtually all FGF2 bound to the pericellular matrix is engaged
with HS, rather than the FGF receptor (FGFR). These HS-
binding sites form non-random networks of heterogeneously
distributed binding sites. The FGF2 moves from one HS-binding
site to another in these networks, which determine whether it
undergoes confined motion (,110 nm) or substantial translocation
(mm) in the pericellular matrix. The spatial organisation, the
relative selectivity, and the availability of HS-binding sites thus lie
at the heart of the mechanisms regulating the transport of FGF2 in
matrices.
Results and Discussion
FGF2-Nanoparticle Possesses Similar Activity to Free
FGF2
To examine, at single molecule resolution, the distribution and
dynamic fluctuations of the FGF2 morphogen in the pericellular
matrix of Rama 27 fibroblasts, we have used a new generation of
10 nm diameter gold nanoparticle probes [25]. The nanoparticles
bear only one TrisNiNTA tag [26,27], so they can specifically and
stoichiometrically label the FGF2 (poly-histidine tagged FGF2,
His-FGF2, see Materials and Methods). It has been demonstrated
that, in the extrasynaptic membrane, protein diffusion parameters
are similar when using probes as different as 500 nm diameter
latex beads, 30 diameter nm quantum dots, and small organic dyes
of ,1 nm [28,29]. Thus, within the pericellular matrix of Rama
27 cells, the 10 nm nanoparticles used here are not expected to
interfere with the diffusion of the FGF2. Moreover, the N-
terminus of FGF2 is an appropriate location for conjugation of a
probe, because it is opposite the binding site for FGFR and the
canonical heparin binding site and there are natural N-terminal
extensions of FGF2 that do not affect its ability to bind heparin
and activate FGFRs [30–32]. The Rama 27 cell line is
representative of the mammary stroma from which it was derived;
for example, it differentiates towards an adipocyte phenotype [33].
Its cytoplasm peripheral to the nucleus is very thin (,2 mm) and
flat, which allows it to be used for two-dimensional tracking of
molecules in its pericellular matrix (thickness ,1 HS chain).
Moreover, purified HS from Rama 27 cells has been extensively
characterised at the level of its FGF2 binding properties and the
ability of this HS to act as a co-receptor and enable the growth-
stimulatory activity of FGF2 [11].
Following purification, the functionality of FGF2-nanoparticle
conjugates (one FGF2 for one nanoparticle, FGF2-NP) was
assessed. At equimolar concentration, FGF2-NP was as potent as
unlabelled His-FGF2 protein in stimulating DNA synthesis
(Figure 1A). Similarly, FGF2-NP stimulated the sustained phos-
phorylation of fibroblast growth factor receptor substrate-2 (FRS2)
and of mitogen-activated protein kinases (MAPK) p42/44MAPK,
which are established signalling events downstream of the FGFR,
to the same extent as unlabeled His-FGF2 (Figure 1B). A heparin-
derived dodecasaccharide, DP 12, will prevent the binding of
FGF2 to cellular HS by direct competition and replace endoge-
nous HS in the formation of stable signalling complexes between
the FGF2 and the FGFR [34]. A similar phosphorylation of FRS2
and of p42/44MAPK was observed in the presence or absence of
the dodecasaccharide (Figure 1B). These results demonstrate that
the FGF2-NP conjugate has the same growth-stimulatory and
signalling activity as the free protein. As these effects are dose
Author Summary
The development, homeostasis, and repair of animal
tissues requires communication between cells mediated
by effector proteins, which are released from source cells
and must move through the surrounding extracellular
matrix to reach their receptors on target cells. A major
component of the extracellular matrix is the polysaccha-
ride heparan sulfate (HS); it binds the majority of these
effectors and has the crucial function of regulating their
transport. The mechanism underlying this function, how-
ever, is still unknown. To understand how HS regulates the
transport of effectors, in this study we labelled molecules
of the effector protein fibroblast growth factor 2 (FGF2)
each with a gold nanoparticle, which we could visualise
and quantify by electron microscopy and by a new
approach called photothermal heterodyne imaging. By
imaging the gold nanoparticles, we found that the binding
sites for FGF2 on HS are distributed heterogeneously in the
extracellular matrix that surrounds cells in culture. Single
molecule tracking indicated that these binding sites are
organised into local networks that confine the FGF2 and
into paths that allow its translocation over long distances
(up to several micrometers). Thus, the spatial distribution
of the binding sites in HS and their physicochemical
properties of binding are major factors controlling the
transport of effectors in extracellular matrices.
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dependent [35], FGF2-NP conjugates and unlabelled FGF2 will
be interacting with the HS co-receptor and FGFR similarly.
Heterogeneous Distribution of FGF2 Binding Sites within
the Pericellular Matrix
Since the FGF2-NP possessed the same activity as unlabelled
FGF2, we were able to take advantage of the imaging versatility of
the gold nanoparticle probe. Its electron density enables ready
detection by TEM, while its strong plasmon absorbance allows
optical imaging and tracking of individual NPs by PHI. In a first
set of experiments, we examined whether the spatial distribution of
binding sites for FGF2 in the HS of the pericellular matrix of
fibroblasts was homogenous or heterogeneous. Previous coarser
grained immunofluorescence and immunohistochemical data have
shown that, although protein-binding structures in HS may be
expressed differently between different matrices, within a partic-
ular matrix these have an apparently amorphous spatial distribu-
tion [20,36,37]. However, they have not had sufficient resolution
to determine the distribution of such binding structures within a
matrix.
TEM. Living Rama 27 fibroblast cells were incubated with
FGF2-NP (550 pM or 2.8 nM), washed, and sheets of plasma
membrane and associated pericellular matrix were prepared for
TEM (Figure 2A,B) [38]. Similar experiments performed with
TrisNiNTA nanoparticles alone (TrisNiNTA-NP) demonstrated
the absence of non-specific binding of the nanoparticle probe
(Figure 2C).
FGF2 bound to the pericellular matrix may interact with HS or
form a complex with the FGFR. Measurement of the numbers of
binding sites corresponding to FGFR and HS on cells are difficult,
due in part to the large number of HS sites often preventing
saturation (reviewed in [32]). The consensus of a large body of
data is that there are ,100- to 1,000-fold more HS-binding sites
than FGFR in Rama 27 (Table S1 and [39]) and other cells
[32,40,41] To demonstrate that FGF2-NP was indeed bound to
cellular HS, a heparin-derived dodecasaccharide (DP12), which
has previously been shown to bind to FGF2 at least as well as
heparin/HS [34], was used to compete with the endogenous HS
for binding to FGF2-NP. In the presence of DP12, little cell
labelling was observed, even with the highest concentration of
FGF2-NP (2.8 nM) (Figure 2D,E). Since DP12 enables, rather
than competes for, the interaction between the FGF2 and FGFR
(Figure 1B and [34]), the remaining labelling that was observed
will correspond to FGF2 engaged with FGFR. By counting the
number of FGF2-NP in the presence or absence of DP12, we
found that in these conditions the HS-binding sites for FGF2 on
Rama 27 fibroblasts significantly outnumber the FGFR binding
sites by 200-fold (Figure 2E). This ratio is in line with the
consensus ratio of HS and FGFR binding sites for FGF2 found in
Rama 27 cells (Table S1 and [39]), though we note it is an
underestimate, since the many areas with no nanoparticles
observed in the presence of DP12 were excluded from the
analysis. Such areas with no nanoparticles were not observed in
the absence of DP12. The number of FGF2-NP was also reduced
to barely detectable levels by competition with 50 mM FGF2
(Figure 2E) and with both DP12 and 50 mM FGF2 (Figure 2E). No
significant difference was observed in the number of FGF2-NP
when competed by FGF2, DP12, or FGF2 and DP12, due to the
low numbers of particles counted per micrograph. However, the
low numbers are in accord with cell binding assays (Table S1
[33,40–42]), and it is thus reasonable to attribute the residual
FGF2-NP observed in the presence of DP12 to the ternary
complex of FGF2-NP:DP12:FGFR rather than to non-specific
binding. This is corroborated by the observation that FGF2-NP in
the presence of DP12 elicits a normal signalling response in the
cells (Figure 1).
Inspection of the distribution of FGF2-NP bound to HS in the
pericellular matrix suggests that the growth factor is clustered
(Figure 2A,B). To determine if this was the case, Ripley’s K-
function (see Materials and Methods) was used to analyse the
distribution of FGF2-NP. At the lower concentration (550 pM),
the FGF2-NP were significantly clustered within a 22 nm to
131 nm range, with a maximum deviation out of the 99%
confidence interval occurring at a radius of 32 to 60 nm
(Figure 2F). At the higher concentration (2.8 nM), FGF2-NP were
clearly clustered over most measureable length scales, ,22 nm to
.400 nm (Figure 2F). These data demonstrate that the HS-
Figure 1. FGF2-NP stimulates DNA synthesis and the phos-
phorylation of FRS2 and p42/44MAPK to the same extent as free
FGF2. (A) DNA synthesis was determined in serum-starved Rama 27
fibroblasts by the incorporation of [3H] thymidine into DNA 18 h after
the addition of growth factor (see Materials and Methods), as follows:
BSA, negative control with no growth factor; FGF2 (55 pM final) or
FGF2-NP (55 pM) in the presence (+) or not (2) of 10 mg/mL heparin-
derived dodecasaccharide (DP12). The results are the mean 6 SD of
triplicate wells of two experiments (n= 6). Student’s t test was
performed to compare the values. The t values (Prob.|t|) for BSA
against the four conditions tested in the presence of FGF2 are shown in
parenthesis on the top of the corresponding bar graph. Significant
differences are observed. No significant difference was observed in
between the four conditions of FGF2 stimulation (|t|.0.05). (B) Serum-
starved Rama 27 fibroblasts were stimulated with 55 pM FGF2 or 55 pM
FGF2-NP for 10 min or 40 min in the presence (+) or not (2) of 10 mg/
mL DP12. The Tyr196 phosphorylated form of FRS2 and the doubly
phosphorylated Thr183/202/Tyr185/204 forms of p42/44MAPK were detected
using appropriate antibodies. The same blot was re-probed with anti-
actin to show the level of loading of the gels. BSA, negative control with
no growth factor added to the cells.
doi:10.1371/journal.pbio.1001361.g001
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binding sites for FGF2-NP have a heterogeneous distribution
within the pericellular matrix. Both concentrations of FGF2-NP
used in these TEM experiments were above that required to elicit
a maximum stimulation of DNA synthesis, 55 pM (Figure 1).
However, these concentrations of FGF2-NP cannot saturate all
possible binding sites in HS, since the polysaccharide expresses a
wide range of structures that bind FGF2 with affinities ranging
from 1028 to 1023 M [11,34,42].
PHI. PHI [43–45] allows the detection and tracking of single
metal nanoparticles as small as 2 nm. The optical stability of gold
nanoparticles means that there is no equivalent of photobleaching
or photoblinking, so that detection of an individual nanoparticle
can be performed over arbitrarily long times. The intensity of the
photothermal signal scales as the volume of the metal nanopar-
ticle, because it is proportional to its absorption cross-section
[44,45]. Therefore, the number of labelled FGF2 proteins in the
images (e.g., Figures 3–5) and in the lower panels of Videos S1, S2,
S3 can be extracted directly from the intensity of the photothermal
signal.
FGF2-NP was added at a final concentration of 22 pM or
220 pM to Rama 27 fibroblasts (living or fixed) for 30 min, and
the unbound material in the culture medium was removed by
washing the cells before observation (Materials and Methods).
Figure 3A and 3B are representative images at different
magnifications (1006100 mm and 10610 mm, respectively) of
living cells incubated with 22 pM of FGF2-NP. Further
10610 mm images of living and fixed cells labelled with 22 pM
FGF2-NP can be seen in Figure 4. In Figure 3A, two cells can be
seen, with their pericellular matrix labelled with FGF2-NP. Note
that the pericellular matrix above the nuclei (Figure 3A, white
arrow) appears unlabelled, because it is largely out of focus, as this
is the only place where the cells are thicker than ,2 mm. Non-
specific binding was determined as for the TEM experiments, with
NPs functionalised with TrisNiNTA, but not conjugated to FGF2.
No labelling with nanoparticles was observed, but there was a
signal from mitochondria (Figure 3C, white arrows). Mitochondria
have been demonstrated to give a weak photothermal signal, but
this is readily distinguishable from that produced by nanoparticles,
because it is diffuse rather than punctuate and bleaching is
apparent within 10 s [46]. Competition for binding of FGF2 was
achieved by adding DP12 (Figure 3D) and/or unlabelled FGF2
(Figure 3E,F) with the FGF2-NP. In the presence of DP12,
unlabelled FGF2 or both, very little FGF2-NP was detected
(Figure 3D, E, and F). When fixed cells were incubated with
440 pM FGF2-NP, labelling was very strong and, due to imaging
being diffraction limited, individual FGF2-NP are difficult to
discern (Figure 3G). In contrast, much less FGF2-NP is observed
in heparinase treated cells incubated with 440 pM FGF2-NP
(Figure 3H). By using this higher concentration of FGF2-NP, there
was sufficient signal in heparinase treated cells to estimate the
difference in the levels of FGF2-NP. The number of pixels giving a
photothermal signal in heparinase-treated cells is over 8-fold lower
than in control cells. Heparinases can only fully digest pure HS in
vitro, whereas on cells sufficient HS in the pericellular matrix is
resistant to digestion to give a small but measureable level of
binding (e.g., [47]). Thus, the 8-fold decrease in the amount of
FGF2-NP observed here is in accord with the competition with
DP12 and together these demonstrate that FGF2-NP is indeed
associated with HS in the pericellular matrix, rather than a protein
Figure 2. FGF-2 NP in the pericellular matrix are clustered. TEM
of plasma membrane sheets reveals clustering and the heterogeneous
spatial distribution of FGF2-NP at high resolution. Five hundred and fifty
pM (A) or 2.8 nM (B) of FGF2-NP were added to living cells before
washing, plasma membrane sheet preparation, and fixation. No
labelling was observed when using 2.8 nM of control nanoparticles
(non-specific binding control with NP-TrisNiNTA, not conjugated to
FGF2) (C). (D) 2.8 nM FGF2-NP in the presence of 50 mg/mL heparin-
derived dodecasaccharide (DP12). In this condition, FGF-2 binding to
the HS of the pericellular matrix was abolished, but not the interaction
with the FGFR. The little labelling that was observed corresponded to
complexes of FGF2-NP with FGFR and DP12. Scale bar, 200 nm.
Representative images. (E) Average number of nanoparticles per mm2
(mean +/2 SD) for 550 pM (purple), 2.8 nM FGF2-NP (green). Labelling
was strongly reduced in the presence of 50 mg/mL of DP12 (grey) for
both concentrations of FGF2-NP. Little labelling was also observed
when 550 pM of FGF2-NP was added to the cell with an excess of
unlabelled FGF2 protein (50 mM) in the absence (white) or in the
presence (stripped) of DP12. The number of photomicrographs of
1.578 mm per 1.578 mm or 1.578 mm per 2.1 mm analysed were 69 for
550 pM FGF2-NP, 65 for 550 pM FGF2-NP in the presence of DP12, 63
for 550 pM FGF2-NP in the presence of unlabelled FGF2, 57 for 550 pM
FGF2-NP in the presence of DP12 and unlabelled FGF2, and 27 for
2.8 nM FGF2-NP and 116 for 2.8 nM FGF2-NP in the presence of DP12.
Non-parametric Kolmogorov-Smirnov performed on the data gave the
following p values: 550 pM FGF2-NP against 550 pM FGF2-NP with
DP12, p= 0; 550 pM FGF2-NP against 550 pM FGF2-NP with excess
FGF2, p=0; 550 pM FGF2-NP against 550 pM FGF2-NP with DP12 and
excess FGF2, p = 0; 550 pM FGF2-NP against 2.8 nM FGF2-NP,
p= 2.12883E29 all 2.8 nM FGF2-NP against 2.8 nM FGF2-NP with
DP12, p= 2.22045E216. (F) FGF2-NP clustering at 550 pM (purple) and
2.8 nM (green) was characterised by K-function analysis (Materials and
Methods). 24 and 27 photomicrographs of 1.578 mm per 1.578 mm were
analysed, respectively. Values of L(r)-r above the 99% confidence
interval (CI) (black) indicate significant clustering within the defined x-
axis radius values (r). Clustering of FGF2-NP was observed at 550 pM
and its extent increased with FGF2-NP concentration.
doi:10.1371/journal.pbio.1001361.g002
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Figure 3. Specific binding of FGF2-NP to living and fixed cells, as revealed by photothermal heterodyne microscopy (PHI). (A, B)
FGF2-NP (22 pM) was incubated for 30 min with Rama 27 fibroblasts before washes and image acquisition by PHI. (A) Image of 1006100 mm of living
cells. The x- and y-axes are in mm. Nucleus is shown (white arrow). (B) Zoom in of a 10610 mm area of (A). The x- and y-axes, in mm, giving the
corresponding position in panel (A). Clear labelling was observed. (C) 22 pM TrisNiNTA-NP, not conjugated to FGF2, were used to determine non-
specific binding. No labelling with nanoparticles was observed. However, some mitochondria (white arrows), which can give a signal in PHI, were
observed. The signal arising from mitochondria is easily distinguishable from the signal of gold nanoparticles, notably because it bleaches [46]. (D)
Living cells were incubated with 220 pM FGF2-NP in the presence of 50 mg/mL of DP12 for 30 min. In this condition, FGF2-NP binding to the HS of
the pericellular matrix was abolished, but the FGF2-NP still bound FGFR. The labelling that was observed, therefore, corresponded to FGF2-NP bound
to FGFR. Note that when binding of FGF2-NP to HS was abolished no labelling was observed in many of the 10610 mm images. (E) Fixed cells were
incubated with 22 pM FGF2-NP in the presence of 50 mM of unlabelled FGF2 for 30 min. In this condition, labelling was strongly reduced due to the
competition between the FGF2-NP and the large excess of unlabelled FGF2. (F) Fixed cells were incubated with 22 pM FGF2-NP in the presence of
unlabelled FGF2 (50 mM) and DP12 (50 mg/mL) for 30 min. In this condition, almost no labelling was observed. (G) Fixed cells were incubated with
440 pM FGF2-NP for 30 min, showing very strong labelling (52%618 pixels labelled, mean 6 SD, n= 28 images of 16 mm2). (H) Fixed cells incubated
with heparinases I, II, and III overnight prior to incubation with 440 pM FGF2-NP for 30 min show greatly reduced labelling (6%62.8 pixels labelled,
mean6 SD, N= 19 images of 16 mm2). The dotted line in the upper left-hand corner indicates a background signal from a mitochondrion. Such areas
were avoided for the analysis. (I) Cells in SDM were incubated overnight with chondroitinase and then fixed and incubated with 440 pM FGF2-NP. The
strong labelling (49%614 of pixels labelled, mean 6 SD, N=20 images of 16 mm2) is indistinguishable from the untreated control in panel G.
doi:10.1371/journal.pbio.1001361.g003
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such as FGFR. Since DP12 would compete for binding of FGF2-
NP to dermatan sulfate (chondroitin sulfate B) and chondroitin
sulfate E and heparinase digestion can only be partial, cells were
also subjected to chondroitinase digestion to determine if there was
a significant contribution of chrondroitin sulfates to FGF2-NP
binding. There was no discernable effect on the level of labelling
following chondroitinase treatment of the cells (Figure 3I). The
heparinase and chondroitinase digestions and the competition
with DP12 demonstrate that the overwhelming majority of the
FGF2-NP is bound to HS in the pericellular matrix rather than
another glycosaminoglycan or protein. This strengthens the
conclusion from TEM experiments that the binding of FGF2-
NP is specific and that the overwhelming majority of the FGF2 is
bound to HS rather than FGFR.
Inspection of the PHI images indicates that the FGF2-NP in the
pericellular matrix of fibroblasts is distributed heterogeneously
(Figures 3A,B and 4). Since the intensity of the photothermal
signal is proportional to the number of nanoparticles, this shows
that the binding sites in HS for FGF2-NP in the pericellular matrix
tend to be clustered, which results in areas with a high intensity of
photothermal signal and areas where there are no FGF2-NP.
Together, the TEM and PHI images show that FGF2-NP is
essentially all bound to HS in the pericellular matrix of Rama 27
fibroblasts (Figures 2 and 3). The spatial distribution of the FGF2-
NP is heterogeneous and this will depend on the spatial
organisation of its HS-binding sites and their relative selectivity
for FGF2. It should be noted that the concentration of FGF2-NP
used in PHI is considerably lower than in the TEM experiments,
simply because at higher concentrations there would be too much
signal to resolve individual FGF2-NP or clusters of FGF2-NP (e.g.,
Figure 3G), due to the diffraction limited spatial resolution
(,220 nm) of the optical images. Consequently, the heteroge-
neous distribution of HS-binding sites for FGF2-NP observed by
PHI reflects the most readily available and/or the highest affinity
binding sites. Our experiments show that the FGF2 binding sites in
HS are clearly clustered and range from length scales correspond-
ing to a few FGF2 protein diameters to the size of a single HS
chain (,100 nm) and to several HSPG molecules (100 s of nm).
This results in a high local concentration of FGF2 in specific areas
of the pericellular matrix of Rama 27 fibroblasts. Vyas and
collaborators have recently shown that hedgehog, another HS
interacting morphogen, exhibits a hierarchical organization at the
cell surface from the nanoscale to visible clusters that have distinct
functions [1]. In addition, it has been shown that the range of
FGF9 signalling in developing tissues is limited by its ability to
dimerize and its affinity for extracellular matrix HS [2]. Though
there is no evidence for similar dimerization of FGF2, it has been
reported that the binding of FGF2 to heparin oligosaccharides
demonstrates a length-dependent cooperativity, apparent at DP8
and above [48]. Such cooperative binding to HS may affect the
observed distribution of FGF2 in the pericellular matrix.
Interestingly, the degree of clustering of FGF2 in the pericellular
matrix is concentration dependent (Figure 2) and it has been
previously demonstrated that FGF2 signalling in development
[49,50] and in cultured cells [35] elicits different cellular responses
according to the concentrations of FGF2. Thus, the concentration-
dependent changes in the clustering of FGF2 we observed may
contribute to the subsequent generation of different signals.
FGF2 Is Mobile in the Pericellular Matrix of Fibroblasts
In PHI, images are acquired by serial scans along the x-axis.
The presence of lines (Figure 4A, rectangles) rather than spots
(Figure 4A, circles) indicated that some of the FGF2-NP were
moving along the direction of the scan in the pericellular matrix of
living cells. It is important to note that FGF2 bound to HS in
pericellular and extracellular matrices remains associated with
these. It does not readily exchange into the bulk culture medium in
the absence of competing exogenous soluble HS or heparin
[32,51,52], though it may exchange into the medium within and
nearby the matrix and then re-bind. Thus, these results
demonstrate that FGF2-NP bound to HS of the pericellular
matrix is mobile within the matrix.
Experiments performed in living cells were repeated in fixed cells,
which will prevent the diffusion of the protein core of the HSPG,
though the protein binding sites in the HS chains will be largely
unaffected. This is because the overwhelming majority of glucos-
Figure 4. FGF2-NP is mobile in the pericellular matrix of Rama 27 fibroblasts. FGF2-NP (22 pM) was incubated for 30 min with Rama 27
fibroblasts before washes and image acquisition by PHI. (A) Image of 10610 mm part of a living cell. The x- and y-axes correspond to the relative
position of this picture within a 100 mm6100 mm image that was acquired first (not shown). Static FGF2-NP molecules appear as bright spots (circle),
while ones moving along the direction of the scan (x-axis) appear as short lines (rectangle), due to the scanning image acquisition mode. (B and C)
Images acquired in the same 10610 mm area of a fixed cell at two different time points (interval of 70 min). While some FGF2-NP molecules are static
(circle) others have moved (rectangle).
doi:10.1371/journal.pbio.1001361.g004
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Figure 5. An individual FGF2 undergoes several modes of diffusion. Representative trajectories of individual FGF2-NP in the pericellular
matrix of Rama 27 fibroblast cells. FGF2-NP (22 pM) was incubated with living (A and B) or fixed (C, D, and E) Rama 27 fibroblasts before washes and
PHI tracking. Representative trajectories of individual FGF2-NP are shown with their duration, in seconds, given using the same colour code used to
trace the trajectory. (A and C) The trajectories were superimposed on the corresponding image acquired before the tracking acquisition. Scale and
position axes are shown. In (B) all trajectories shown were acquired within the same area of the same cell. (E) Zoom in on three trajectories of (D).
Note that the two trajectories denoted with an * correspond to two different FGF2 molecules (in green and purple) which were at the same location
in the pericellular matrix, but at several minutes of interval and then followed the same path. (B, D, and E). Scale bars are shown on the image. The
time course of the two FGF2 ligand trajectories within a dashed red oval in (A) and (D) corresponds to Movies S1 and S3 given in the Supporting
Information section.
doi:10.1371/journal.pbio.1001361.g005
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amine residues in protein binding domains are N-sulfated.
Intriguingly, when FGF2-NP was added to fixed cells, the growth
factor was still mobile (Figure 4B,C). It has been shown that some
isolated membrane and glycosyl-phosphatidylinositol (GPI) an-
chored proteins might retain some mobility following fixation [53].
However, the cross-linking of the numerous endogenous protein
partners of the HS chains and of the protein core of the HSPGs will
severely restrict the freedom of the chains and protein cores,
including GPI-anchored ones and, hence, their contribution to the
observed motion. The mobility persisting in fixed cells cannot
depend on cellular biochemistry. Comparison of sequential images
taken in the same cell area at 70 min intervals shows that some of
the immobile FGF2-NP have disappeared and that new FGF-NP
have appeared. This suggests that there is a dynamic transition
between immobile and mobile FGF2-NP (Figure 4B,C, dash circle).
FGF2 Molecules Undergo Several Modes of Diffusion in
the Pericellular Matrix of Fibroblasts
PHI imaging indicated that some of the FGF2-NP was mobile
in the pericellular matrix of both living and fixed cells. Such
movement represents the transport of the FGF2 in the pericellular
matrix. Therefore, we quantified the dynamic parameters of the
movement of FGF2-NP by PHI single molecule tracking (see
Materials and Methods). PHI tracking of gold nanoparticles
uniquely allows very long trajectories to be captured, with a time
frame of 42 ms and a pointing accuracy in the x, y dimensions of
,10 nm (Materials and Methods). The motion of the FGF2-NP in
the pericellular matrix is thus approximated to two dimensions.
This is reasonable, given that the scale of the motion of FGF2-NP
cannot exceed the depth of the pericellular matrix (no more than a
single HS chain) by more than an order of magnitude and that the
Rama 27 fibroblastic cells are flat.
FGF2-NP added to the cells will be virtually all associated with
HS. In some experiments DP12 was included to compete for
FGF2-NP binding to HS and so identify FGF2-NP associated with
the FGFR, as a complex with DP12. Images were taken before
and after the acquisition of tracks, which allowed the superimpo-
sition of tracks on a photothermal image (Figure 5A,C). It is
apparent from inspection of exemplar trajectories and videos
(Figure 5, Videos S1, S2, and S3) that an individual FGF2
molecule associated with HS undergoes various types of motion,
ranging from confinements in a small area (e.g., expanded box,
Figure 5E) to different types of travel phases, where the FGF2-NP
undergoes substantial net displacement. The travel phases include
motion that is nonetheless quite convoluted and interspersed with
what appears to be confined motion (e.g., Figure 5D, grey track in
dotted red circle, 434 s long), as well as straight-forward
displacement that is more or less directional (e.g., Figure 5B,
18 s magenta track). When different tracks are superimposed
(Figure 5B,D–E), this indicates that different FGF2-NP, which
were tracked at different times in the same field, could travel the
same path. Moreover, since there is a succession of different types
of motion in individual tracks, it is clear that FGF2-NP were not
restricted to any particular type of motion and were able to make
transitions between these.
Discrimination between different diffusive behaviours was
achieved by means of a plot of the distance travelled against
displacement (Figure 6A) with a frame window of 12 points (0.5 s)
(Materials and Methods ‘‘PHI Single Molecules Tracking Anal-
ysis’’ and Figure S1). Using this approach the data fell into five
groups. As an illustration of this analysis, the exemplar tracks
shown in Figure 6B and 6C are colour-coded according to the
corresponding five diffusive behaviours in Figure 6A. All the
physical parameters (diffusion coefficient, confinement diameter,
mean square displacement over time, etc.) were calculated, as
appropriate, for each group.
Group 1 corresponded to immobile/highly confined FGF2-NP.
This was indistinguishable from the background noise of the tracker
in a plot of distance travelled versus displacement (Figure 6). Group
2 corresponded to confined diffusion, where the FGF2-NP was
clearly mobile in a plot of distance travelled versus displacement
(Figure 6), yet confined to a small area. Group 3 was simple diffusive
motion. Group 4 corresponded to slow directed diffusion, and
Group 5 corresponded to long and fast directed diffusion. Only the
last was restricted to living cells and for this reason was considered
separately from Group 4, while Groups 2, 3, and 4 were statistically
significantly different (Table S4).
Note that the mean square displacement (MSD) against time
curves obtained for these five diffusive behaviours fit the physical
description of protein diffusion, which has been characterised by
others (Figure 7) [54]. This further supports our discrimination of
the movement of FGF2-NP into these groups.
In living cells, individual FGF2 molecules spent most of their
time (,83%) in confined motion (Groups 1 and 2, Table S2A,B),
which alternated with simple diffusive motion (Group 3, Table
S2A,B, ,13% of time). Occasionally (3% of time), the FGF2-NP
underwent slow directed diffusion (Group 4, Table S2A,B) or
more rarely fast directed diffusion (Group 5, Table S2A,B). It is
important to note that the proportion of fast and directed diffusion
may be underestimated, because the FGF2-NP undergoing such
motion is near the speed limit of the tracker (,0.2 mm2/s)
(Figure 7A, Figure S2, Table S2A,B).
In the pericellular matrix of fixed cells, FGF2-NP spent more
than 90% of their time in confined diffusion (Groups 1 and 2,
Table S2C,D), with a commensurate decrease in simple diffusion
(Group 3) and slow directed diffusion (Group 4) compared to living
cells. Moreover, fast directed diffusion was absent (Group 5).
Increasing the concentration of FGF2 from 22 pM to 220 pM had
a clear effect on some of the parameters of the different types of
motion, particularly on fixed cells (Table S2A–D, Figure 7B).
However, it had no detectable effect on the proportion of time that
an FGF2 spent in the five different types of motion (Table S2).
The signal intensity at each point in the trajectories was grouped
into that corresponding to a single nanoparticle (below 0.147, see
Materials and Methods) and that corresponding to two or more
nanoparticles (Figure S3). In confined motion (Groups 1 and 2),
FGF2 is more likely to be sufficiently close to one or more other
FGF2 molecules to cause the photothermal signal to double or
more than when the FGF2 undergoes diffusive motion (Figure S3).
Thus, when FGF2 undergoes diffusive motion, it is less likely to be
associated with other FGF2 molecules.
FGF2 Associated with Complexes of DP12 and FGFR
Competition by DP12 prevents FGF2-NP from binding to HS
in the pericellular matrix, but allows the formation of a ternary
signalling complex of FGF2-NP:DP12:FGFR. Thus, experiments
with DP12 allow the motion of FGF2-NP associated with the
signalling complex to be studied in isolation. In living cells, FGF2-
NP associated with DP12 and FGFR spent 94% of their time
undergoing confined motion (Groups 1 and 2, Figure S4) and just
5.5% of their time undergoing simple and slow directed diffusion.
Despite the measurements being made on living cells, there was no
Group 5 motion (long/fast directed diffusion). Thus, FGF2-NP
associated with DP12 and FGFR were less mobile than FGF2-NP
associated with HS (Figure S4 compared to Figure 7 and Table
S2). This may reflect the progressive engagement of intracellular
signalling platforms by the FGF2 ligand and DP12 co-receptor
activated FGFR [55].
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Properties of Confined Motion of HS-Associated FGF2 in
the Pericellular Matrix of Fibroblasts
The change in MSD with time for the highly confined FGF2-
NP motion (Group 1, Table S2) was not fitted by an exponential
with an asymptote (Figure 7B), as the data were too close to the
background noise of the tracker when using a time window of
12 points (0.5 s). However, we noted that the MSD increased with
time compared to the control immobile nanoparticles fixed in
polyvinyl alcohol, demonstrating that some of these FGF2
molecules, if not all, were indeed mobile. This mobility over time
can be observed on exemplar trajectories (Figure 6B,C, black
colour). Moreover, this mobility was somewhat higher in living
Figure 6. Heterogeneous diffusive behaviour of individual FGF2 in the pericellular matrix. (A) Plot of displacement (mm2) against
distance travelled (mm) for FGF2-NP trajectories shown in (B) (analysis window of 12 points, 0.504 s). Five groups were defined that discriminate the
different diffusive behaviours of the FGF2-NP (see Materials and Methods). Group 1 (Black) immobile/high confinement (fitted according to the
calculated parameter for NP embedded in thin film of polyvinyl alcohol on a glass coverslip); Group 2 (grey) confinement; Group 3 (green) simple
diffusion; Group 4 (magenta) slow directed diffusion; Group 5 (blue) fast, directed diffusion (only observed in living cells). (B and C) Representative
FGF2-NP trajectories at the surface of living (B) or fixed (C) Rama 27 fibroblast cells colour-coded according to the five diffusion groups defined in (A).
Duration and scale bar are given on the figure.
doi:10.1371/journal.pbio.1001361.g006
Figure 7. Mode of diffusion of FGF2-NP in the pericellular matrix. (A) Average mean square displacement (MSD) as a function of time (mean
6 sem) showing the different diffusion modes of diffusion of FGF2-NP (22 pM) in the pericellular matrix of living and of fixed Rama 27 cells. The
number of subtrajectories corresponding to each mode of diffusion is indicated in parentheses. As not all subtrajectories lasted the duration shown
on the graph, the minimal number (at late time) and the maximal number (early time) of subtrajectories are given (minimal-maximal). A similarly
colour-coded trajectory is shown in the insert; scale bar, 1 mm. (B) MSD versus time interval (mean 6 sem) for the confined diffusion modes of FGF2-
NP (22 pM and 220 pM) in the pericellular matrix of living and fixed Rama 27 cells. The number of subtrajectories analysed are shown in parentheses.
As not all subtrajectories lasted the duration shown on the graph, the minimal number (at late time) and the maximal number (at early time) of
subtrajectories are given (minimal-maximal). NP embedded in PVA (polyvinyl alcohol) corresponds to isolated NPs embedded in thin film of polyvinyl
alcohol on the surface of a glass coverslip, so are immobilized nanoparticles, and measures the inherent noise of the tracker. For Group 2, average
MSD as a function of time data were fitted according to Equation (4), given in Materials and Methods. For clarity a quarter of the data points are
shown in the graph. (C) Zoom in of (B) showing the MSD over time interval (mean 6 sem) before confinement arises. (D) Calculated instantaneous
coefficient of diffusion (Dins) according to Equation (2), given in Materials and Methods. (E) Calculated diameter of confinement (dconf). The p values
according to the Kolmogorov-Smirnov non-parametric test are given in Table S3.
doi:10.1371/journal.pbio.1001361.g007
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compared to fixed cells. For confined subtrajectories of Group 2,
the MSD over time was fitted using an exponential equation
(Equation 4, Materials and Methods), with the asymptote of the
curve corresponding to diameter of confinement (dconf)
(Figure 7B,E) and the slope of the curve corresponding to the
instantaneous diffusion coefficient (Dins) (Figure 7C,D). Moreover,
since PHI of the nanoparticle probe is optically stable, our data
covered sufficient time to estimate the asymptote directly from the
graph. In fixed cells, the diameter of confinement was 94 nm
(Figure 7B,E), whereas in living cells, it was 106 nm. These values
diverged when the concentration of FGF2 was increased 10-fold to
220 pM, with the diameter of confinement in fixed cells being
reduced to 61 nm, but increased to 122 nm in living cells.
What might the confined motion of FGF2 represent physically
in the pericellular matrix? It may be due to the movement of a HS
chain to which the FGF2-NP is bound (Figure 8, (c)). Such a view
is consistent with the dimension of HS chains: the disaccharide
unit is ,1 nm and a chain is 40 to 160 disaccharides, so the chain
is ,40 to 160 nm long. In addition, the movement of the HSPG
core protein may also contribute, since membrane proteins are
known to undergo such confinements (Figure 8, (b)) [56].
Alternatively, HS chains and HSPG core proteins may actually
be quite immobile. This is supported by the fact that there are
many endogenous binding partners of HS chains and HSPG core
proteins, which may severely restrict their movements (Figure 8,
asterisks). In this instance the FGF2-NP would then be moving
around a local network of binding sites on the chains (Figure 8, (a)).
Our data do allow some discrimination between these
explanations of the confined motion of FGF2. Unlike the HSPG
core proteins, the HS chains will be largely immune to fixatives,
including amine reactive ones such as used here. However, the
many endogenous proteins bound to HS chains are likely to be
immobilised by fixation, so restricting their mobility. Indeed,
fixation did reduce the diameter of confinement (Figure 7B,E).
This reduction is likely to identify a component of the confined
motion that may be due to the movement of the HS chain and/or
the confined motion of the core protein. In fixed cells, raising the
concentration of the FGF2 10-fold decreased the diameter of
confinement (from 94 nm to 61 nm; Figure 7B,E), which is
consistent with the increased occupancy of binding sites for FGF2
in a local network of HS chains having a crowding effect. This
would decrease the capacity of the FGF2 to explore the entire
network of binding sites. Thus, the results suggest that the confined
motion of FGF2 represents the combined motion of the HSPG
core protein carrying the chain, including the HS chain to which
the FGF2 is bound, and of the translocation of FGF2 from binding
Figure 8. Schematic representation of the HSPG in the pericellular matrix. In the crowded pericellular matrix (macromolecular
concentration of ,400 mg/mL), proteins and proteoglycans interact with each other. Only HSPG proteoglycans (in black and grey), the FGF2 (in
green) and few other HS partners (in blue), are represented here for clarity. The HS-binding partners, which may be membrane-associated or
‘‘soluble’’ in the matrix, include growth factors, cytokines, chemokines, enzymes, matrix proteins, and numerous cell-surface receptors. Proteoglycan
core proteins (black, inserted in the membrane) are shown with their HS chains (dark grey lines), which are between 40 to 160 nm long. Along these
chains, dark grey rectangles represent strong binding sites for FGF2, and light grey rectangles represent weaker binding sites for FGF2. These binding
sites form non-random networks of heterogeneously distributed binding sites within which the FGF2 moves by translocating from one site to
another (a). A path of the FGF2 is shown by green arrows and some of its successive positions marked as a green circle. This motion of the FGF2 is
independent of the motion of the protein core of the HSPG itself (b). Movement of the HS chains (c) to which the FGF2 is attached may also
contribute to the motion of the FGF2 within the pericellular matrix. Note that the many endogenous binding partners of HS chains and HSPG core
proteins may, in some conditions, severely restrict the diffusion of the protein core and of the HS chains (asterisks).
doi:10.1371/journal.pbio.1001361.g008
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site to binding site along the same or to a neighbouring HS chain
(Figure 8). This translocation would involve the FGF2 in successive
cycles of dissociation into the local medium and rebinding. It is
likely that the translocation of the FGF2 from site to site is aided
considerably by the fact that electrostatic binding dominates the
kinetics of the interaction of FGF2 with HS, which ensures rapid
rebinding following dissociation into the local medium [7,10,34].
The time FGF2 spends undergoing free diffusion in bulk medium
is short compared to the measurement time (42 ms), since the
tracker cannot measure such a fast event; a much higher time
resolution would be needed to identify directly such processes.
FGF2 possesses three binding sites for HS, one canonical, higher
affinity site (Kd ,1028 M to 1026 M) [11,42], a secondary site of
mM affinity, and a third of even lower affinity [31], which will also
increase the probability of re-binding following dissociation.
Moreover, these multiple sites may allow the FGF2 to bind to a
site on a neighbouring chain, while still attached to its original site
and so to move by sliding from one site on the polysaccharide to
another.
In living cells, increasing the concentration of FGF2 did not
decrease the diameter of confinement, but rather increased it.
Thus, the greater freedom of HSPG core proteins and HS chains
in the living cells allowed an adaptation to the increased
concentration of FGF2. This might occur by the FGF2 competing
for binding sites in the HS chains occupied by endogenous
proteins, causing the chains to disengage from these and so
increase their capacity for movement. In addition, the signalling
activity of the FGF2-activated FGFR may affect the movement of
FGF2 in the pericellular matrix through inside-out signalling and
by changes in protein synthesis altering the extracellular heparin
interactome of the pericellular matrix. It is also possible that the
increased dissociation of endogenous proteins from HS caused by
the increased concentration of FGF2 may have an impact on the
intracellular signalling activity of these proteins, which could in
turn impact the movement of FGF2 or the HSPG. None of these
hypotheses are mutually exclusive.
Properties of Simple and Directed Diffusive Motions of
HS-Associated FGF2-NP in the Pericellular Matrix of
Fibroblasts
The long tracking times that PHI allows demonstrate that
confinements are interspersed by the various forms of non-
confined motion (Groups 3–5, Figure 6, Videos S1, S2, S3, and
Table S2). The displacement observed for individual FGF2-NP
undergoing motion corresponding to Groups 3, 4, and 5 (Figures 6
and 7, Videos S1, S2, S3, and Table S2) is well beyond the scale of
a single HS chain (Figure S2). For the fast and directed motion
(Group 5), the diffusion coefficient value (Table S2A,B;
,0.2 mm2/s) and the shape of the MSD over time (Figure 7) are
consistent with the values measured for cytoskeleton-driven active
transport [54,56]. Thus, FGF2-NP motion corresponding to
Group 5 may be due to the engagement of the HSPG core
protein with cytoskeletal motor proteins. This is supported by the
observation that it only occurs in living cells.
Simple and slow directed diffusive motion (Groups 3 and 4,
Table S2) occurs in both living and fixed cells. In living cells, a 2-
fold increase of the frequency of these non-confined motions
(Table S2A,B) was observed compared to fixed cells (Table
S2C,D). Therefore, the mobility of the protein core of the HSPG is
likely to contribute to these types of motion. However, such
motions were still observed in fixed cells. Thus, this suggests that
an important mechanism underpinning simple and slow directed
diffusive motion is the FGF2 moving from binding site to binding
site. The amplitude of displacement of the FGF2 undergoing such
diffusive motion corresponds to more than ,10 HS chains
(Figures 6, 7, and S1, Videos S1, S2, S3). Since the FGF2 does
not dissociate from the pericellular matrix into the bulk cell culture
medium, this indicates that its binding sites on successive HS chains
are sufficiently close to enable it to undergo cycles of dissociation
into the local medium of the matrix and rebinding to neighbouring
sites in HS and/or to slide along and between chains. Therefore,
these data suggest that HS-binding sites on multiple chains are
spatially aligned so that FGF2 can undergo such major transloca-
tions. This is reinforced by the direct observation of some
trajectories in fixed cells, such as in Figure 5E (asterisk), where
two different FGF2 molecules (in green and purple) were at the
same physical location in the pericellular matrix, but separated by
several minutes and followed the same path. The observation of
such super-imposable trajectories, which last for 101 s for one FGF2
molecule and more than 20 min for the second one, supports the
notion that the HS chains form a well-defined path of binding sites
for FGF2.
Implications for the Structure of Matrices
Though HS has a degree of selectivity for its numerous protein
partners [20–24], it is clear that the motifs in the polysaccharide
recognised by FGF2 are representative of the binding sites of a
large number of other effector proteins [12]. Thus, the binding
sites in HS probed by FGF2-NP in the present work represent
structures in the pericellular matrix that will be similarly
recognised by not just other FGFs but also many unrelated
binding effectors. The data suggest that the HS chains possessing
these binding sites in the pericellular matrix may be organised in
two quite distinct ways: local networks, which support confine-
ment, and paths, which support non-confined motion (Figure 8).
Therefore, this long-range organisation of binding sites in the
pericellular matrix is likely to impose similar types of motion on
many other HS-binding effectors. The detailed physical properties
of motion of each protein would depend on a number of factors.
One is the actual binding parameters of the protein for HS, which
will determine the properties of the cycles of dissociation and
rebinding. This conclusion is supported by recent studies on the
ensemble diffusion of FGF7, FGF10 [57], and FGF9 [2]. Another
is the level of expression of the protein-binding structures in the
HS of a particular matrix, though the HS interactome may be at
least as important. This is due to the interactome determining the
number of free binding sites in HS. These factors are not
independent. For example, introducing a HS-binding effector into
a matrix, as done in the present experiments, may alter the
balance of interactions of HS chains with the polysaccharide’s
endogenous interactome and hence the spatial distribution of the
effector’s binding sites.
All extracellular matrices contain the same general recipe of
molecules: HS and HS-binding proteins. Although many effectors
mediating cell-cell communication bind similar sites in HS [12],
their selectivity and affinity may differ [20–24]. Therefore, the
structured networks of HS-binding sites presented to effector
proteins by a matrix may be sufficiently different in the fine detail
of the protein’s binding properties to allow the tuning of the
movement of different effectors. This would contribute to the
shape of effector gradients and the rate of their delivery to target
cells and ultimately to their signalling receptors on the cell
membrane.
Conclusion
By using a novel gold nanoparticle probe to label FGF2
stoichiometrically, we have been able to determine the spatial
distribution of FGF2 from the nano- to the microscale and to
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measure the dynamics of individual FGF2 at unprecedented time
scales. Here we show that the binding sites in the sugar chains of
HSPGs are directly involved in the transport of FGF2 within the
pericellular matrix. An important mechanism whereby they
achieve this is by their HS chains forming local networks
( = confinements) and paths ( = non-confined motion) of binding
sites for FGF2. We propose that extracellular matrices are highly
structured rather than amorphous. Networks and paths of HS-
binding sites consequent of such structure would represent a
fundamental mechanism that enables HS-binding effectors to
move through matrices and, therefore, drive cell communication
in development and disease.
Materials and Methods
Buffers
Phosphate-buffered saline (PBS) is 8.1 mM Na2HPO4, 1.2 mM
KH2PO4, 140 mM NaCl, and 2.7 mM KCl. Acquisition buffer is
10 mM Hepes pH 7.4, 140 mM NaCl, 5 mM KCl, 2 mM CaCl2,
2 mM MgCl2, and 11 mM glucose, supplemented with 250 mg/
mL bovine serum albumin (BSA). Binding buffer is a 9:1 mixture
of PBS:acquisition buffer, supplemented with BSA, 10 mg/mL.
KOAc buffer is 25 mM Hepes, pH 7.4 (KOH), 115 mM
potassium acetate, and 2.5 mM MgCl2.
FGF2 Conjugated to Gold Nanoparticles (Stoichiometry
1:1)
Ten nm diameter Mix-capped gold nanoparticles (HS-
PEG:CVVVT-ol, ratio 30:70) bearing only one TrisNiNTA
function per nanoparticle (TrisNiNTA-NP, n=1) were prepared
and coupled to in-house-produced FGF2 ligand, as described in
[25]. Briefly, purified poly-histidine-tagged FGF2 (His-FGF2) at
6.5 mM final concentration was mixed with purified TrisNiNTA-
NP, n=1, at 160 nM final concentration in a 10 mL final volume
of PBS supplemented with 0.005% Tween (v/v) (PBST). The
reaction was left 2 h at room temperature and PBST then added
to a final volume of 200 mL. Centrifugation was performed for
90 min at 17,000 g 4uC, and the supernatant, corresponding to
free soluble FGF2 (unlabelled), was removed. The pellet was
resuspended in 200 mL of PBST and centrifuged again; a total of
five cycles of centrifugation were performed. At the end, the pellet,
which corresponds to the purified FGF2-NP conjugate (stoichi-
ometry 1:1), was resuspended in PBS at a final concentration of
11 nM. Pure recombinant FGF2 protein concentration was
calculated using its value of S280 nm (1.6610
4). FGF2-NP
conjugate concentration was calculated using the epsilon value
of 10 nm gold nanoparticles, S520 nm (9.5610
8) [25].
Cell Culture
Rama 27 fibroblasts were cultured in Dulbecco’s modified
Eagle’s medium (DMEM) supplemented with 10% (v/v) fetal calf
serum, 50 ng/mL insulin, and 50 ng/mL hydrocortisone [33].
DNA Synthesis Assays
Proliferation assays were performed as described previously
[35]. Briefly, cells were rendered quiescent by 30 h incubation in
step down medium (SDM; Dulbecco’s modified Eagle’s medium
supplemented with 250 mg/mL BSA) before the addition of
growth factors for 18 h. [methyl- 3H] thymidine (ICN, Basing-
stoke, UK) was then added directly to the culture medium for 1 h,
and radioactivity in DNA, precipitated with 5% (w/v) trichlor-
oacetic acid, was measured by liquid scintillation counting.
FRS2 and p42/44MAPK Phosphorylation
SDS PAGE and Western blotting were performed as described
in [35] with minor variations. Briefly, after 18 h incubation in
SDM, FGF2 or NP-FGF2 (55 pM) were added for 10 or 40 min at
37uC. Plates were placed on ice, washed with PBS, and Laemmli
buffer added to extract the proteins. Anti-phospho-p44/42 MAPK
(Thr183/202/Tyr185/204) (E10) and anti-phospho FRS2-a (Tyr196)
were from Cell Signalling Technology (Hitchin, UK). Anti-actin
was from Sigma-Aldrich Co. Secondary peroxidase-labelled anti-
IgG antibodies (anti-rabbit and anti-mouse) were from Pierce UK.
Visualization was performed using enhanced chemiluminescence
(SuperSignal West Dura Substrate, Pierce).
TEM Experiments
Thirteen mm diameter glass coverslips were washed in ethanol,
rinsed with milliQ water, and then used as is. Rama 27 fibroblasts,
seeded on a coverslip, were rinsed 3 times with PBS and incubated
in 500 mL SDM for 2 h. Three washes with 500 mL PBS were
performed and cells were incubated with 100 mL of binding buffer
with control TrisNiNTA-NP or FGF2-NP, in absence or presence
of DP12 (50 mg/mL) and/or excess of unlabelled FGF2 protein
(50 mM). Coverslips were then washed 3 times with PBS and
plasma membrane sheets on EM grids were prepared as described
in [38]. Cells on a coverslip were pressed onto two coated grids.
The coverslip was turned over and 200 mL of KOAc buffer added
quickly around the grids to separate them from the coverslip and
to generate plasma membrane sheets on the grids (inner leaflet
face up). Samples were then fixed with a solution of 4% (w/v)
paraformaldehyde and 0.1% glutaraldehyde (v/v) in KOAc for
15 min. The fixative was quenched with three washes with 25 mM
glycine in PBS for 10 min in total. Five washes of 2 min were then
performed with de-ionized water, and the grids were incubated
with a solution of 1.8% (w/v) methyl cellulose, 0.3% (w/v) uranyl
acetate for 10 min on ice, and then individually picked up with
5 mm copper wire loops and left to dry for at least 10 min before
storage or viewing. Plasma membrane sheets were digitally imaged
using an FEI Tecnai G2 120 kV transmission electron microscope
and data analysed as described in [38].
Photothermal Heterodyne Imaging (PHI) Set-Up
PHI, alternatively called LISNA (Laser Induced Scattering
around NanoAbsorber), allows detection and tracking of single
noble metal nanoparticles down to 2 nm diameter. PHI is a
confocal technique with a focal depth of,1.6 mm. The optical set-
up of the microscope was as described previously [44,58], with a
heating beam intensity of 4 mW/cm2 and an integration time of
1 ms for image acquisition and 7 ms for tracking. Before each
experiment, the microscope was calibrated by measuring the mean
signal and performing tracks on isolated NP embedded in a thin
film of polyvinyl alcohol. Signal to noise ratio was ,400. To track
NP in the pericellular matrix, we used a triangulation procedure
knowing the point spread function of the microscope [45]. A 2-D
Gaussian fit based on the signal measurement of three points
around the NP gives the NP position and the signal intensity. The
sampling time Dt is 42 ms. This methodology allows tracking of
one NP at a time with a pointing accuracy of ,10 nm. In our
experiments, the calculated diffusion coefficient for NPs embedded
in polyvinyl alcohol (a measure of the noise and pointing accuracy
of the tracker) was 4.102660.9.1026 mm2/s (mean 6 sem) with a
mean square displacement (MSD) after 60 s of
0.176102361.761026 mm2 (mean 6 sem). This gives a deviation
length of 13 nm61.3 nm after 60 s (mean 6 sem), which is well
below the calculated parameter for mobile FGF2-NP in the
pericellular matrix of living and of fixed cells (Table S2, Figure 7B).
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In PHI, the signal is proportional to the volume of nanoparticle,
and n nanoparticles of similar diameter close to each other (#10–
15 nm) will provoke an n-fold increase in the PHI signal intensity
[43,45]. Therefore, the number of nanoparticles in close vicinity of
the tracked one can be estimated at each acquisition point of a
trajectory. Signal intensity for a single FGF2-NP was calculated at
0.1160.037 volt (mean 6 STD, n=600,000).
PHI Data Acquisition
Thirteen nm diameter glass coverslips were washed in ethanol,
rinsed with milliQ water, and then used as is. Rama 27 fibroblasts,
seeded on a coverslip, were rinsed 3 times with PBS and incubated
in 500 mL SDM for 2 h. Three washes with 500 mL PBS were
performed and cells were incubated with 100 mL of binding buffer
with control TrisNiNTA-NP (22 or 222 pM) or FGF2-NP
(22 pM6200 pM unlabelled FGF2) in the absence or presence
of DP12 50 mg/mL for 30 min at 37uC. Additional controls were
performed by adding FGF2-NP at 22 pM in the presence of a
large excess of unlabelled FGF2 (50 mM) or in the presence of
unlabelled FGF2 (50 mM) and DP12 (50 mg/mL). Three washes
with 500 mL of PBS were performed and cells were placed in
500 mL of acquisition buffer for immediate microscope acquisition.
For fixed cells, following the incubation in SDM, cells were
washed 3 times with 500 mL of PBS, rinsed once with 500 mL of
fresh paraformaldhehyde solution 4% (w/v) in PBS and then
incubated 45 min at room temperature in 500 mL paraformald-
hehyde 4% (w/v). PBS washes (561 mL) were then performed
and 500 mL of binding buffer added. Fixed cells were kept at 4uC
in the fridge overnight prior to the addition of the appropriate
nanoparticle sample. In some experiments, fixed cells were treated
with heparinases I, II, and III (10 mU/mL each in a 100 mM
sodium acetate and 0.1 mM calcium acetate buffer, pH 7.0;
produced in-house, a kind gift of Prof. Jerry Turnbull, University
of Liverpool). Heparinase treatment was achieved by incubating
fixed cells overnight at 37uC with 200 mL of the three enzymes at
10 mU/mL prior to washing and labelling with FGF2-NP.
Chondroitinase treatment was achieved by adding 20 mL chon-
droitinase ABC (Sigma) at 333 mU/mL in 100 mM Tris acetate,
pH 8.0, to cells in 2 mL step-down medium and incubating
overnight prior to washing, fixation, and labelling with FGF2-NP.
Percent of Labelled Versus Unlabelled Area
PHI images (30630 mm) were converted to 8 bit greyscale
images, thresholded, and colours were inverted. Areas of images
464 mm (devoid of mitochondrial signal) were selected, duplicat-
ed, and the percentage of labelled pixels (black) versus unlabelled
pixels was calculated for each 464 mm image using ImageJ
software.
PHI Single Molecule Tracking Analysis
All analyses were performed using MATLAB R2009a. Subse-
quent graphs and statistics analysis were performed using
OriginPro 8.5 software.
Each trajectory was characterised by the number of points it
contained, N, and four vectors of length N representing sampling
time, x and y position, and signal strength, denoted:
Ti,Xi,Yi,Si, i~1 . . .N:
Each trajectory was split into segments of length s frames, and the
net displacement and total distance travelled for each segment was
calculated. This created a set of displacement-distance pairs (Pj, Qj)
for each trajectory:
Pj~
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
(Xsj{Xs(j{1)z1)
2
z(Ysj{Ys(j{1)z1)
2
q
j~1 . . . t
N
s
s
Qj~
Xs{1
n~1
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
(Xs(j{1)znz1{Xs(j{1)zn)
2
z(Ys(j{1)znz1{Ys(j{1)zn)
2
q
j~1 . . . t
N
s
s:
The displacement-distance pairs of multiple trajectories were
plotted on a scatter plot.
First, the selection of obvious confined, slow diffusive, and fast/
directed diffusive events, etc., on dozens of trajectory images were
performed to obtain the corresponding set of displacement-
distance pair (Pj, Qj) values on the scatter plot. This step was
repeated using different segments of length s. This allowed the
identification of the best choice of the length s and best
partitioning of the scatter plot to discriminate the different
behaviours within the trajectories. At the limit length sR1, one
calculates displacement over time for movement between two
points and confinement cannot be measured. As the length s
progressively increases, different types of movement inevitably
become averaged. With windows of 6, 12, and 18 points we found
that the analyses were found to be similar (Figure S1). A window of
12 points, s=12, corresponding to a time interval of 0.504 s, was
used for all subsequent analyses, because it was likely to be more
robust than the windows of 6 and 18 points. This led to the
identification of five groups, as shown in Figure 6A. ‘‘Group 1’’
(black) was defined according to the parameters obtained for
tacking NPs embedded in thin film of polyvinyl alcohol. Note that
when plotting the Group 1 population according to the MSD over
time, a difference of mobility over time between polyvinyl alcohol
embedded nanoparticles and FGF2-NP is seen (Figure 7B). Thus,
Group 1 corresponds to the population of molecules that are non-
mobile and/or too confined to be accurately discriminated from
the noise of the tracker within the time frame of 0.504 s used
(displacement lower than 0.036 mm2 with a distance travelled
under 0.16 mm within the time frame used). ‘‘Group 2’’ (grey)
corresponds to mobile but confined events (displacement lower
than 0.11 mm2 within the time frame used, but excluding the
events of Group 1); ‘‘Group 3’’ (green) to simple/slow diffusion
(displacement between 0.11 to 0.33 mm2 within the time frame);
‘‘Group 4’’ (magenta) to directed diffusion (displacement between
0.33 to 0.68 mm2 within the time frame); and ‘‘Group 5’’ (blue) to
unidirectional diffusion events that were only observed in living
cells (displacement over 0.68 mm2 within the time frame). These
parameters were then used for batch processing all PHI data and
for dividing each trajectory into sub-trajectories (Figure 6B,C).
Sub-trajectories were constructed by joining together trajectory
pieces adjacent in the original trajectory data and belonging to the
same behavioural group k in the displacement-distance (Pj, Qj)
scatter plot. For a specified group k, each sub-trajectory was
characterised by its length, M, and four vectors of length M
representing sampling time, x and y position, and signal strength S,
denoted:
T
(k)
i ,X
(k)
i ,Y
(k)
i ,S
(k)
i i~1 . . .M:
These were further analysed to compute the mean squared
displacement (MSD) over time (t) within each sub-trajectory
according to the following expressions:
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t~T
(k)
i {T
(k)
1
MSD(t)~(X
(k)
i {X
(k)
1 )
2
z(Y
(k)
i {Y
(k)
1 )
2 i~1 . . .M ð1Þ
The over-bar represents averaging over all sub-trajectories in
group k of duration at least t. The diffusion coefficients (D) were
calculated according to the following equations [54]:
MSD(t)~4Dt (Simple diffusion) ð2Þ
MSD(t)~4Dtz(nt)2 (Directed motion) ð3Þ
The confinement domain size was obtained by fitting the MSD
over time plot of the trajectories in confined motion to the
following exponential equation:
MSD(t)~d2conf 1{exp {
4Dins
d2conf
t
 ! !
: ð4Þ
v in Equation (4) is the velocity and dconf is the measured diameter
of confinement and corresponds to the asymptote of the curve.
Dins is the instantaneous diffusion coefficient (before the confine-
ment arises) and corresponds to the slope of the curve at the origin.
Statistics
Statistical analyses were performed using OriginPro 8.5
software. The p values were obtained using Kolmogorov-Smirnov
non-parametric test and confirmed using Mann-Whitney non-
parametric test. The t values were obtained using Student’s t test
(parametric).
Supporting Information
Figure S1 Mean square displacement over time and diameter of
confinement of individual FGF2 in living cells obtained using three
different frame windows. (A, C) Average mean square displace-
ment (MSD) as a function of time (mean 6 sem) showing the
different modes of diffusion of FGF2-NP (22 pM) in the
pericellular matrix of living Rama 27 cells for the three exemplar
trajectories shown in Figure 6B. Discrimination between different
diffusive behaviours was achieved by means of a plot of the
distance travelled against displacement (Figure 6A) with a frame
window of 6, 12, and 18 points. Groups 1 to 5 were defined as
described in ‘‘Materials and Methods.’’ The number of sub-
trajectories corresponding to each mode of diffusion is indicated in
parentheses. As not all subtrajectories lasted the duration shown
on the graph, the minimal number (at late time) and the maximal
number (early time) of subtrajectories are given (minimal-
maximal). (B) Calculated diameter of confinement (dconf).
According to the Kolmogorov-Smirnov non-parametric test, the
p values for Dconf data are 0.18792 between frame window of 6
and 12 points, 0.13716 between frame window of 12 and
18 points, and 0.36331 between frame window of 6 and 18 points.
(TIF)
Figure S2 Cumulative frequency (%) graph of the diffusion
coefficient and the mean square displacement (MSD) of FGF2-NP
sub-trajectories within each mobility group. Sub-trajectories were
constructed by joining together trajectory pieces adjacent in the
original trajectory data and belonging to the same mobility group
(Groups 1 to 5, from confined to long and fast directed diffusion,
Figure 7). Overall diffusion coefficient (A) and MSD (B) of each
subtrajectory within each mobility group and for each condition
tested (insert, panel A) were calculated (Materials and Methods),
and a cumulative frequency graph in percent (%) was generated
using OriginPro 8.5 software. More than 95% of the sub-
trajectories undergone by an individual NP and belonging to the
confined diffusion mobility group (Group 2) present a mean square
displacement below 0.03 mm2, which corresponds to a maximum
displacement of 170 nm. However, for the sub-trajectories
belonging to Groups 3, 4, and 5, the displacement observed for
individual FGF2-NP is well beyond the scale of a single HS chain
(50% over for Group 3, 100% for Groups 4 and 5).
(TIF)
Figure S3 Increased clustering of FGF2-NP with confinement.
(A) Measured PHI signal intensity in volt (v) for the given
trajectory (partial) of a single FGF2-NP as a function the time (s) in
a living cell (22 pM NP-FGF2) (cf., Movie S1). A similar colour
code is used for both the trajectory and the graph. The grey frame
delimits the signal intensity corresponding to a single, isolated
nanoparticle. (B) Proportion (%) of single isolated FGF2-NP and of
FGF2-NP having one or more FGF-2-NPs in close vicinity ($2
nanoparticles) according to their diffusive behaviour, in living
(black) and fixed cells (grey) (22 pM of FGF2-NP). Confined
consists of both Groups 1 and 2, as defined in Figure 6. Simple
represents simple diffusion (Group 3). Directed is slow to fast
unidirectional diffusion (Groups 4 and 5). Signal intensity was
acquired at each point during tracking (every 42 ms). Number of
points for each diffusive group for living (black) and fixed (grey)
cells are shown in parentheses. In confined motion, FGF2-NP is
more likely (over 62%) to be sufficiently close to one or more other
FGF2 molecules (10–15 nm) to cause the photothermal signal to
double or more than when the FGF2 undergoes diffusive motion.
(TIF)
Figure S4 Mode of diffusion of individual FGF2 in the presence
of DP12 in the pericellular matrix of living Rama 27 fibroblasts.
FGF2-NP (22 pM) in the presence of 50 mg/mL DP12 was
incubated for 30 min with Rama 27 fibroblasts before washes and
acquisition by PHI. For comparison, the data for FGF2-NP in the
absence of DP12 (data from Figure 7) are shown alongside. (A)
Average mean square displacement (MSD) as a function of time
(mean 6 sem) showing the different modes of diffusion of FGF2-
NP (22 pM) in the presence or absence (data from Figure 7) of
50 mg/mL DP12 in the pericellular matrix of living Rama 27 cells.
Groups 1 to 5 were defined as described in ‘‘Materials and
Methods.’’ The number of subtrajectories corresponding to each
mode of diffusion is indicated in parentheses. As not all
subtrajectories lasted the duration shown on the graph. the
minimal number (at late time) and the maximal number (early
time) of subtrajectories are given (minimal-maximal). (B) MSD
versus time interval (mean6 sem) for the confined diffusion modes
of FGF2-NP (22 pM) in the presence or absence (data from
Figure 7) of 50 mg/mL of DP12 in the pericellular matrix of living
Rama 27 cells. The number of subtrajectories analysed are shown
in parentheses. As not all subtrajectories lasted the duration shown
on the graph, the minimal number (at late time) and the maximal
number (at early time) of subtrajectories are given (minimal-
maximal). NP embedded in PVA (polyvinyl alcohol) are isolated
nanoparticles embedded in thin film of polyvinyl alcohol on the
surface of a glass coverslip, thus corresponding to immobilized
nanoparticles, which measures the inherent noise of the tracker.
For Group 2, average MSD as a function of time data were fitted
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according to Equation (4), given in Materials and Methods. For
clarity a quarter of the data points are shown in the graph. (C)
Zoom in of (B) showing the MSD over time interval (mean 6 sem)
before confinement arises. (D) Calculated instantaneous coefficient
of diffusion (Dins) according to Equation (3), given in Materials
and Methods. (E) Calculated diameter of confinement (dconf). (F)
Dynamic parameters obtained by PHI for NP-FGF2 in the
presence of 50 mg/mL DP12. N Subtraj, number of subtrajectories
within the given group; % N Subtraj, percentage of the number of
subtrajectories for the given group, compared to the total number
of subtrajectories within all the groups (mean 6 sem); sem,
Standard Error of the Mean; % time Subtraj, percentage of the
time spent within the given group compared to the total duration
of all the groups (mean 6 sem); Duration Subtraj, Average
duration, in seconds (s) of the subtrajectories within the group
(mean 6 sem); D is the average diffusion coefficient in mm2/s
(mean 6 sem). For Group 1, the average diffusion coefficient was
calculated according to Equation (2) using the overall duration and
MSD value of each sub-trajectory (see Materials and Methods).
For Group 2, the instantaneous diffusion coefficient (Dins) was
calculated according to Equation (2) by fitting the MSD against
time plots for the first 6 points. The average diffusion coefficient
(Dav) was calculated according to Equation (2) using the overall
duration and MSD value of each sub-trajectory. For Group 3, the
average diffusion coefficient was obtained according to the
Equation (2) by fitting the MSD against time plots. For Groups
4 and 5, the average diffusion coefficient values and the velocity (n)
were calculated according to Equation (3) by fitting the MSD
against time plots. According to the Kolmogorov-Smirnov non-
parametric test, the p values between NP-FGF2 in the presence
and absence of DP12 are 0.15224 for Dins data (D); 8.19346E25
for dconf data (E); and 4.63832E253 (Group 1), 3.03134E227
(Group 2), 1.3215E229 (Group 3), and 1.77525E213 (Group 4) for
Dav data (F).
(TIF)
Table S1 Number and affinity of FGF2 binding sites on Rama
27 cells. FGF2 was iodinated using IODOGEN (Pierce-Warriner,
Chester, UK) as the oxidant, exactly as described [39]. Binding of
[125I]-FGF2 to Rama 27 fibroblasts was performed using
previously described methods [39,59]. The binding parameters
(Kd, number of receptors, single versus two-site model) were
determined by analysing the pooled data from four experiments by
non-linear curve fitting using the LIGAND program [60]. The
high affinity binding sites are established to correspond to the
interaction of FGF2 with FGFR and the heparan sulfate co-
receptor [30,47,61]. The low affinity site corresponds to the
interaction of FGF2 with HS, because it is competed by soluble
heparin. 1Mean 6 sem calculated from data pooled from four
independent experiments, each with four replicates. 2Analysis of
the binding data with the LIGAND program [60] indicated that a
two-site model was superior to a one-site model. Thus a two-site
model yielded an improved runs test and a reduced mean square
(p=0.005), while the other measures of goodness of fit were
unchanged. 3ne, no evidence. When a two-site model was used to
fit the data from binding experiments performed in the presence of
1 mg/mL heparin, regardless of the starting values of the binding
parameters, the model would not converge. Thus the lower-
affinity HS-binding sites on Rama 27 cells are not detectable in the
presence of competing heparin.
(DOC)
Table S2 Dynamic parameters obtained by PHI. Groups 1 to 5
were defined as described in ‘‘Materials and Methods’’ for each of
the four conditions tested (living or fixed cells incubated with
22 pM or 220 pM FGF2). N Subtraj, number of subtrajectories
within the given group; % N Subtraj, percentage of the number of
subtrajectories for the given group, compared to the total number
of subtrajectories within all the groups (mean 6 sem); sem,
Standard Error of the Mean; % time Subtraj, percentage of the
time spent within the given group compared to the total duration
of all the groups (mean 6 sem); Duration Subtraj, Average
duration, in seconds (s) of the subtrajectories within the group
(mean 6 sem); D is the average diffusion coefficient in mm2/s
(mean 6 sem). For Group 1, the average diffusion coefficient was
calculated according to Equation (2) using the overall duration and
MSD value of each sub-trajectory (see Materials and Methods).
For Group 2, the instantaneous diffusion coefficient (Dins) was
calculated according to Equation (2) by fitting the MSD against
time plots for the first 6 points. The average diffusion coefficient
(Dav) was calculated according to Equation (2) using the overall
duration and MSD value of each sub-trajectory. For Group 3, the
average diffusion coefficient was obtained according to the
Equation (2) by fitting the MSD against time plots. For Groups
4 and 5, the average diffusion coefficient values and the velocity (v)
were calculated according to Equation (3) by fitting the MSD
against time plots. The p values according to Kolmogorov-
Smirnov non-parametric test performed on the diffusion values are
shown in Table S4.
(DOC)
Table S3 The p values according to the Kolmogorov-Smirnov
non-parametric test performed on the values of the diameter of
confinement. For Group 2 (confined diffusion), average MSD as a
function of time data were fitted according to Equation (4), given
in Materials and Methods. The asymptote of the curve gives the
diameter of the area within which the FGF2-NP is confined
(Figure 7). Non-parametric Kolmogorov-Smirnov test was then
performed on the values of the diameter of confinement.
(DOC)
Table S4 The p value according to Kolmogorov-Smirnov non-
parametric test performed on the diffusion values shown in Table
S1. For Group 2, values are given for the instantaneous diffusion
coefficient and the average diffusion coefficient (between brackets).
* The p values according to Mann-Whitney test were over 0.01.
(a–h) Kolmogorov-Smirnov non-parametric test performed on the
average diffusion values of Groups 2 and 3 (a, b, c, d) and Groups
3 and 4 (e, f, g, h) for living cells, 22 pM (a, e), Living cells, 220 pM
(b, f); Fixed cells, 22 pM (c, g); and Fixed Cells, 220 pM (d, h).
Calculated p values are (a) 0, (b) 0, (c) 0, (d) 1.1597E2118, (e) 0, (f)
8.29343E2168, (g) 1.12411E268, and (h) 3.61153E236.
(DOC)
Video S1 Multiple modes of movement of FGF2-NP in the
pericellular matrix of a living cell. This movie shows the time
course of one of the FGF2-NP trajectories depicted in Figures 5A
and 6B in the pericellular matrix of a living Rama 27 cell. It covers
about 2,139 s, during which time, one FGF2, labelled with a single
nanoparticle, is tracked and displays multiple confined and non-
confined motions. The signal intensity is displayed simultaneously
at the bottom. A PHI signal intensity of around 0.11 (0.1160.037)
corresponds to 1 nanoparticle. As the measurement is quantitative,
and stable over time, a signal of around 0.2 and over means that
one or more nanoparticles are in close vicinity (10–15 nm) to the
FGF2-NP being tracked. Speed increased 25.56 (QuickTime
Movie, 9.9 MB).
(MOV)
Video S2 Long unidirectional walk of FGF2-NP in the
pericellular matrix of living cells. This movie shows the time
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course of one FGF2 molecule in the pericellular matrix, labelled
with a single nanoparticle, undergoing a long unidirectional
motion before being confined for several minutes. It covers 218 s.
The signal intensity is displayed simultaneously at the bottom. A
signal intensity of around 0.11 (0.1160.037) corresponds to 1
nanoparticle. As the measurement is quantitative, a signal of
around 0.2 and over means that another or more nanoparticles are
in close vicinity (10–15 nm) to the NP-FGF2 being tracked. Speed
increased 2.66 (QuickTime Movie, 4.4 MB).
(MOV)
Video S3 FGF2-NP movement in the pericellular matrix of fixed
cells. This movie shows the time course of one of the FGF2-NP
trajectories depicted in Figures 5D,E and 6C. It covers 435 s,
during which time one FGF2 molecule, labelled with a single
nanoparticle, is tracked and displays confined and non-confined
motions in the pericellular matrix of a fixed cell. The signal
intensity is displayed simultaneously at the bottom. A signal of
around 0.11 (0.1160.037) corresponds to 1 nanoparticle. As the
measurement is quantitative, a signal of around 0.2 and over
means that one or more FGF2-NP are in close vicinity (10–15 nm)
to the FGF2-NP being tracked. Speed increased 6.26 (QuickTime
Movie, 6.4 MB).
(MOV)
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